Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.4.2 to v3.4.3, with no other content changes indicated.
    Difference
    0.1%
    Check dated 2026-03-12T02:29:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma to the study context and introduced the Genetic and Rare Diseases Information Center resource. Removed the government funding lapse notice and updated the revision to v3.4.2.
    Difference
    0.6%
    Check dated 2026-02-11T12:18:22.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and NIH operating status and updated revision to v3.4.1 (replacing v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:37:45.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Show glossary added and footer updated to Revision: v3.4.0. Capitalization corrections were made for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:19:45.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Results Submitted status is now shown on the study page, with related topics including Ovarian cancer and MedlinePlus Genetics added, and the revision updated to v3.3.4, replacing No Results Posted and v3.3.3.
    Difference
    0.3%
    Check dated 2026-01-14T02:16:10.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Explicit related topics 'Ovarian cancer' and 'MedlinePlus Genetics' have been removed from the study page. This reduces explicit disease context and related resource navigation for users seeking ovarian cancer information.
    Difference
    0.2%
    Check dated 2026-01-07T01:28:59.000Z thumbnail image

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.